Amino Acid Transport and Metabolism in Myeloid Function

Regulation of amino acid availability and metabolism in immune cells is essential for immune system homeostasis and responses to exogenous and endogenous challenges including microbial infection, tumorigenesis and autoimmunity. In myeloid cells the consumption of amino acids such as arginine and try...

Full description

Bibliographic Details
Main Authors: Marie Jo Halaby, Tracy L. McGaha
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.695238/full
id doaj-675bd9ec60f046f8bae4ddd60a8d75a0
record_format Article
spelling doaj-675bd9ec60f046f8bae4ddd60a8d75a02021-08-12T08:50:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-08-011210.3389/fimmu.2021.695238695238Amino Acid Transport and Metabolism in Myeloid FunctionMarie Jo Halaby0Tracy L. McGaha1Tracy L. McGaha2Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, CanadaTumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, CanadaDepartment of Immunology, The University of Toronto, Toronto, ON, CanadaRegulation of amino acid availability and metabolism in immune cells is essential for immune system homeostasis and responses to exogenous and endogenous challenges including microbial infection, tumorigenesis and autoimmunity. In myeloid cells the consumption of amino acids such as arginine and tryptophan and availability of their metabolites are key drivers of cellular identity impacting development, functional polarization to an inflammatory or regulatory phenotype, and interaction with other immune cells. In this review, we discuss recent developments and emerging concepts in our understanding of the impact amino acid availability and consumption has on cellular phenotype focusing on two key myeloid cell populations, macrophages and myeloid derived suppressor cells (MDSCs). We also highlight the potential of myeloid-specific of amino acid transporters and catabolic enzymes as immunotherapy targets in a variety of conditions such as cancer and autoimmune disease discussing the opportunities and limitations in targeting these pathways for clinical therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2021.695238/fullmacrophageMDSCamino acidIDO - indoleamine 2 3-dioxygenasearginase (ARG)immune suppression
collection DOAJ
language English
format Article
sources DOAJ
author Marie Jo Halaby
Tracy L. McGaha
Tracy L. McGaha
spellingShingle Marie Jo Halaby
Tracy L. McGaha
Tracy L. McGaha
Amino Acid Transport and Metabolism in Myeloid Function
Frontiers in Immunology
macrophage
MDSC
amino acid
IDO - indoleamine 2 3-dioxygenase
arginase (ARG)
immune suppression
author_facet Marie Jo Halaby
Tracy L. McGaha
Tracy L. McGaha
author_sort Marie Jo Halaby
title Amino Acid Transport and Metabolism in Myeloid Function
title_short Amino Acid Transport and Metabolism in Myeloid Function
title_full Amino Acid Transport and Metabolism in Myeloid Function
title_fullStr Amino Acid Transport and Metabolism in Myeloid Function
title_full_unstemmed Amino Acid Transport and Metabolism in Myeloid Function
title_sort amino acid transport and metabolism in myeloid function
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-08-01
description Regulation of amino acid availability and metabolism in immune cells is essential for immune system homeostasis and responses to exogenous and endogenous challenges including microbial infection, tumorigenesis and autoimmunity. In myeloid cells the consumption of amino acids such as arginine and tryptophan and availability of their metabolites are key drivers of cellular identity impacting development, functional polarization to an inflammatory or regulatory phenotype, and interaction with other immune cells. In this review, we discuss recent developments and emerging concepts in our understanding of the impact amino acid availability and consumption has on cellular phenotype focusing on two key myeloid cell populations, macrophages and myeloid derived suppressor cells (MDSCs). We also highlight the potential of myeloid-specific of amino acid transporters and catabolic enzymes as immunotherapy targets in a variety of conditions such as cancer and autoimmune disease discussing the opportunities and limitations in targeting these pathways for clinical therapy.
topic macrophage
MDSC
amino acid
IDO - indoleamine 2 3-dioxygenase
arginase (ARG)
immune suppression
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.695238/full
work_keys_str_mv AT mariejohalaby aminoacidtransportandmetabolisminmyeloidfunction
AT tracylmcgaha aminoacidtransportandmetabolisminmyeloidfunction
AT tracylmcgaha aminoacidtransportandmetabolisminmyeloidfunction
_version_ 1721209635063463936